— Know what they know.
Not Investment Advice

Financial News

Sentiment -83.0 4022 articles 1726 bullish 1312 bearish Full Index →
Waterdrop (NYSE:WDH) Trading 5.8% Higher  Following Dividend

Waterdrop (NYSE:WDH) Trading 5.8% Higher Following Dividend Announcement

Shares of Waterdrop Inc. Unsponsored ADR (NYSE:WDH – Get Free Report) were up 5.8% during trading on Thursday after the company announced a...
Top Nanotechnology Stocks To Add to Your Watchlist – March 2

Top Nanotechnology Stocks To Add to Your Watchlist – March 25th

Onto Innovation, Nano Dimension, NVE, and Clene are the five Nanotechnology stocks to watch today, according to MarketBeat’s stock screener...
Promising Green Energy Stocks To Add to Your Watchlist – Mar

Promising Green Energy Stocks To Add to Your Watchlist – March 25th

NWTN, Nuvve, NWTN, and Nuvve are the five Green Energy stocks to watch today, according to MarketBeat’s stock screener tool. Green energy...
Best Biotech Stocks To Follow Now – March 25th

Best Biotech Stocks To Follow Now – March 25th

Danaher, Vertex Pharmaceuticals, and ImmunityBio are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool....
Promising Growth Stocks To Follow Today – March 25th

Promising Growth Stocks To Follow Today – March 25th

Prologis, Teledyne Technologies, and Hamilton Lane are the three Growth stocks to watch today, according to MarketBeat’s stock screener tool....
Best Apparel Stocks To Watch Now – March 25th

Best Apparel Stocks To Watch Now – March 25th

ON, Ross Stores, and NIKE are the three Apparel stocks to watch today, according to MarketBeat’s stock screener tool. Apparel stocks are shares...
Top Blockchain Stocks To Research – March 25th

Top Blockchain Stocks To Research – March 25th

Core Scientific, Figure Technology Solutions, and Bitdeer Technologies Group are the three Blockchain stocks to watch today, according to...
Canadian Stocks To Follow Now – March 25th

Canadian Stocks To Follow Now – March 25th

Canadian Natural Resources, Celsius, Canadian National Railway, Canadian Pacific Kansas City, and TC Energy are the five Canadian stocks to watch...
Bitcoin Stocks Worth Watching – March 25th

Bitcoin Stocks Worth Watching – March 25th

IREN, Cipher Mining, and TeraWulf are the three Bitcoin stocks to watch today, according to MarketBeat’s stock screener tool. “Bitcoin...
Best Entertainment Stocks To Watch Today – March 25th

Best Entertainment Stocks To Watch Today – March 25th

Verizon Communications, Walt Disney, DraftKings, Warner Bros. Discovery, and Autodesk are the five Entertainment stocks to watch today, according to...
OSB Group Investor Spotlight: PRS Tailwinds, BTL Leadership,

OSB Group Investor Spotlight: PRS Tailwinds, BTL Leadership, and Faster AI-Powered Lending Platform

OSB Group (LON:OSB) used its first “Investor Spotlight” event to outline why it believes the U.K. private rented sector (PRS) and professional...
Gold Stocks To Follow Today – March 25th

Gold Stocks To Follow Today – March 25th

Newmont, Coeur Mining, Freeport-McMoRan, Agnico Eagle Mines, and First Majestic Silver are the five Gold stocks to watch today, according to...
Bank Stocks To Follow Now – March 25th

Bank Stocks To Follow Now – March 25th

JPMorgan Chase & Co., Bank of America, Citigroup, Wells Fargo & Company, and NU are the five Bank stocks to watch today, according to...
Promising Cryptocurrency Stocks To Watch Now – March 25th

Promising Cryptocurrency Stocks To Watch Now – March 25th

Bitfarms, Galaxy Digital, and HIVE Digital Technologies are the three Cryptocurrency stocks to watch today, according to MarketBeat’s stock...
KalVista Pharmaceuticals Q4 Earnings Call Highlights

KalVista Pharmaceuticals Q4 Earnings Call Highlights

KalVista Pharmaceuticals (NASDAQ:KALV) detailed early commercial traction for EKTERLY, its oral on-demand treatment for hereditary angioedema (HAE),...
Cognyte Software Q4 Earnings Call Highlights

Cognyte Software Q4 Earnings Call Highlights

Cognyte Software (NASDAQ:CGNT) reported fourth-quarter fiscal 2026 results that management said capped “another year of consistent execution,”...
Best Chinese Stocks To Consider – March 25th

Best Chinese Stocks To Consider – March 25th

Charming Medical, Diageo, and UP Fintech are the three Chinese stocks to watch today, according to MarketBeat’s stock screener tool....
Esports Stocks Worth Watching – March 25th

Esports Stocks Worth Watching – March 25th

Motorsport Games, Brag House, Allied Gaming & Entertainment, NIP Group, Esports Entertainment Group, Esports Entertainment Group, and EBET are...
EnQuest H2 Earnings Call Highlights

EnQuest H2 Earnings Call Highlights

EnQuest (LON:ENQ) executives used the company’s 2025 full-year results presentation to highlight higher production, an expanded reserve and resource...
Cybersecurity Stocks To Keep An Eye On – March 25th

Cybersecurity Stocks To Keep An Eye On – March 25th

CrowdStrike, Palo Alto Networks, Fortinet, SentinelOne, BlackBerry, Globant, and NetScout Systems are the seven Cybersecurity stocks to watch today,...
Energy Stocks To Consider – March 25th

Energy Stocks To Consider – March 25th

Tesla, GE Vernova, Exxon Mobil, Chevron, and IREN are the five Energy stocks to watch today, according to MarketBeat’s stock screener tool....
Manufacturing Stocks To Consider – March 25th

Manufacturing Stocks To Consider – March 25th

Taiwan Semiconductor Manufacturing, Applied Materials, Fabrinet, Firefly Aerospace, and Chart Industries are the five Manufacturing stocks to watch...
📰

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors

– Acquisition brings together Excellergy's differentiated trifunctional allergic effector cell response inhibitors (ECRIs) and the development...
Rönesans Holding kündigt neue globale Partnerschaft an

Rönesans Holding kündigt neue globale Partnerschaft an

Rönesans und die SJ Group unterzeichnen strategische Partnerschaft zur weiteren Entwicklung des Industriegebiets DAPEK ISTANBUL, 26. März 2026...
📰

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
Brokerages Set Allogene Therapeutics, Inc. (NASDAQ:ALLO) Tar

Brokerages Set Allogene Therapeutics, Inc. (NASDAQ:ALLO) Target Price at $8.56

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven...
Brokerages Set Coya Therapeutics, Inc. (NASDAQ:COYA) PT at $

Brokerages Set Coya Therapeutics, Inc. (NASDAQ:COYA) PT at $16.00

Coya Therapeutics, Inc. (NASDAQ:COYA – Get Free Report) has received a consensus rating of “Moderate Buy” from the six research...
📰

Govt’s fuel duty cut seen as timely cushion; markets may have passed peak panic: Deven Choksey

India's fuel excise duty cut is a timely move to curb inflation and bolster consumer demand amid global turmoil. Experts believe this proactive step,...
📰

Trooly Brings 45-Minute In-Depth Interviews to Scale with 180 Million Global Respondents

PALO ALTO, Calif., March 27, 2026 /PRNewswire/ -- Trooly, an AI-native research platform, has launched its agent-based architecture to automate...
📰

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

- Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases   - Lead asset Exl-111 builds on proven...
📰

Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older

Pharming announces positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
📰

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

- Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases   - Lead asset Exl-111 builds on proven...
📰

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

- Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases   - Lead asset Exl-111 builds on proven...
📰

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

- Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases   - Lead asset Exl-111 builds on proven...
📰

IBA delivers strong FY 2025 results with solid execution in all segments

Read the entire full-year 2025 results press release here
📰

Rocket pharmaceuticals gets FDA approval (RCKT)

https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-severe-leukocyte-adhesion-deficiency-type-i This information...
Erste Group Bank Has Optimistic View of VRTX FY2027 Earnings

Erste Group Bank Has Optimistic View of VRTX FY2027 Earnings

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Analysts at Erste Group Bank upped their FY2027 earnings estimates for...
M.P. Evans Group (LON:MPE) Insider Tanya Ashton Buys 669 Sha

M.P. Evans Group (LON:MPE) Insider Tanya Ashton Buys 669 Shares of Stock

M.P. Evans Group PLC (LON:MPE – Get Free Report) insider Tanya Ashton acquired 669 shares of the company’s stock in a transaction that...
FY2026 EPS Estimates for OTCMKTS:CPKF Boosted by Analyst

FY2026 EPS Estimates for OTCMKTS:CPKF Boosted by Analyst

Chesapeake Financial Shares Inc. (OTCMKTS:CPKF – Free Report) – Equities researchers at Zacks Research raised their FY2026 EPS estimates...
Rapport Therapeutics (NASDAQ:RAPP) Raised to “Strong-Buy” at

Rapport Therapeutics (NASDAQ:RAPP) Raised to “Strong-Buy” at Truist Financial

Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) was upgraded by research analysts at Truist Financial to a “strong-buy” rating...
Truist Financial Upgrades Sutro Biopharma (NASDAQ:STRO) to S

Truist Financial Upgrades Sutro Biopharma (NASDAQ:STRO) to Strong-Buy

Sutro Biopharma (NASDAQ:STRO – Get Free Report) was upgraded by equities researchers at Truist Financial to a “strong-buy” rating...
Solid Biosciences (NASDAQ:SLDB) Stock Rating Upgraded by Tru

Solid Biosciences (NASDAQ:SLDB) Stock Rating Upgraded by Truist Financial

Solid Biosciences (NASDAQ:SLDB – Get Free Report) was upgraded by stock analysts at Truist Financial to a “strong-buy” rating in a...
Analysts’ Recent Ratings Changes for Westlake (WLK)

Analysts’ Recent Ratings Changes for Westlake (WLK)

Several analysts have recently updated their ratings and price targets for Westlake (NYSE: WLK): 3/26/2026 – Westlake had its price target...
Wedbush Upgrades Rezolute (NASDAQ:RZLT) to “Outperform”

Wedbush Upgrades Rezolute (NASDAQ:RZLT) to “Outperform”

Rezolute (NASDAQ:RZLT – Get Free Report) was upgraded by equities researchers at Wedbush from a “neutral” rating to an...
HC Wainwright Forecasts Strong Price Appreciation for Ocugen

HC Wainwright Forecasts Strong Price Appreciation for Ocugen (NASDAQ:OCGN) Stock

Ocugen (NASDAQ:OCGN – Get Free Report) had its price target upped by investment analysts at HC Wainwright from $7.00 to $10.00 in a note issued...
Brokerages Set Spyre Therapeutics, Inc. (NASDAQ:SYRE) Price

Brokerages Set Spyre Therapeutics, Inc. (NASDAQ:SYRE) Price Target at $60.67

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) has earned a consensus rating of “Buy” from the ten research firms that...
Brokerages Set American Healthcare REIT, Inc. (NYSE:AHR) PT

Brokerages Set American Healthcare REIT, Inc. (NYSE:AHR) PT at $53.67

American Healthcare REIT, Inc. (NYSE:AHR – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen...
« Prev 1 49 50 51 52 53 477 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms